MYELOPROLIFERATIVE NEOPLASMS
Clinical trials for MYELOPROLIFERATIVE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASMS trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for rare blood cancers in early trial
Disease control CompletedThis early-phase study tested a new pill called TQ05105 in 79 adults with certain blood cancers (myeloproliferative neoplasms). The main goals were to find the safest dose and check for side effects. Participants had to be 18 or older and have a specific type of blood cancer. The…
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 08, 2026 13:05 UTC
-
Scientists uncover immune clues to prevent transplant complications
Knowledge-focused CompletedThis study looked at how certain immune cells (regulatory and effector T cells) are involved in graft-versus-host disease (GVHD), a common complication after a stem cell transplant from a donor. Researchers analyzed blood and tissue samples from 146 patients and their family dono…
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:54 UTC